Wake Forest University Health Sciences

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).

1,140 total trials 174 currently recruiting 724 completed early-phase tilt top decile by trial count

Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.

Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.

Top-decile sponsor footprint

Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 44/100

724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,140 total, page 8 of 23

COMPLETED NA

Yoga for Caregivers and Persons With Dementia

NCT05103839

COMPLETED

Aging and Frailty Study

NCT05268991

COMPLETED Phase 3

The POUR (Postoperative Urinary Retention) Study

NCT05276804

COMPLETED NA

System Interventions to Achieve Early and Equitable Transplants (STEPS) Study

NCT05014256

COMPLETED NA

Pelvic Physical Therapy for Sexual Dysfunction in Gynecologic Oncology Survivors

NCT05242770

TERMINATED Early Phase 1

Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab

NCT05204290

COMPLETED NA

Evaluation of a Novel Sutureless Drain Securement Device

NCT05251753

COMPLETED NA

Monitoring and Testing of Blood Pressure in Postpartum Women

NCT05236725

COMPLETED

Prospective Analysis of In Vivo Laparoscopic Microwave Ablation Thermodynamics

NCT05471596

TERMINATED NA

H-coil TMS to Reduce Pain: A Pilot Study Evaluating Relative Efficacy of the H1 vs H7 Coil

NCT04203199

COMPLETED NA

Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes

NCT05175599

COMPLETED Phase 2

Elagolix for Fertility Enhancement Clinical Trial

NCT04039204

COMPLETED NA

MOST EMPOWER: Optimizing An Emotion Regulation Intervention

NCT04317417

COMPLETED NA

Digital Outreach Intervention for Lung Cancer Screening

NCT04083859

COMPLETED NA

Effect of Validated Skills Simulation With the Miya Model

NCT05418764

COMPLETED NA

(YMP) Young Moms Program

NCT05082857

COMPLETED NA

Twilio Well-Child Visit Pilot Open Trial

NCT05189080

COMPLETED NA

Cereset Research In Healthcare Workers During COVID-19

NCT04682197

COMPLETED NA

BE FAST vs. FAST: A Study in the General Public.

NCT06152016

COMPLETED NA

Effect of Clear Masks on Patient Satisfaction With Communication

NCT05088603

COMPLETED

Caretaker in the Cardiovascular Intensive Care Unit (CVICU)

NCT05779683

COMPLETED NA

An Evaluation of Virtual Psychiatric Transition of Care Offered in Behavioral Health

NCT05460078

COMPLETED NA

Super-Supporters - Virtual Care Technology Navigators

NCT06841081

COMPLETED NA

Electronic Frailty Index (eFI)Cacious-Diabetes Care

NCT05047237

COMPLETED NA

Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes

NCT04866823

COMPLETED Early Phase 1

Intensive Preventative Dental Program Pilot Study

NCT07218068

TERMINATED Phase 4

The Effect of Tamsulosin on Postoperative Urinary Retention

NCT04682366

TERMINATED Phase 4

Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment

NCT04707625

COMPLETED

Mapping the Natural History of Parenychymal and Cerebral Perfusion Changes in Acute Ischemic and Hemorrhagic Strokes

NCT05865795

COMPLETED NA

Multisensory Rehabilitation of Hemianopia

NCT04963075

COMPLETED NA

Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings

NCT05030272

COMPLETED NA

A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation

NCT05016310

TERMINATED NA

Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients

NCT04770402

COMPLETED Phase 2

SNIFF - Combo INI+EMPA Trial

NCT05081219

TERMINATED NA

Feasibility of a New Ambulatory Multi-vital Signs Monitor

NCT05562011

COMPLETED NA

A Meditation Intervention on Subconcussive Head Impacts

NCT04225663

COMPLETED NA

Nuts and Oil Pilot Study

NCT04361617

COMPLETED NA

A Telehealth Advance Care Planning Intervention in Those With Mild Cognitive Impairment or Unrecognized Dementia

NCT04912245

COMPLETED NA

Evidence-based Intervention for Improved Head Impact Safety in Youth Football - Aim 1 and Aim 3

NCT04908930

TERMINATED NA

Use of a Non-Invasive Brainstem Neuromodulation Device to Improve Neurovascular Status in Parkinson's Disease

NCT04598828

COMPLETED NA

Testing the Causal Effects of a Civic Engagement Intervention on Health and Wellbeing Among Youth (I-ACTED)

NCT04514133

COMPLETED NA

Menthol and Mint Experimental Tobacco Marketplace (ETM) Study

NCT04879225

COMPLETED NA

Intervention to Reduce Sugar-Sweetened Beverage (SSB) Consumption in Children and Families

NCT04886817

COMPLETED NA

Improving Care Coordination for Adolescents and Young Adults With Cancer

NCT04586127

COMPLETED NA

REJOIN Trial for Older Breast Cancer Survivors

NCT03955627

COMPLETED NA

Diabetes Data-Assisted Remission Trial (DDART)

NCT04663061

TERMINATED NA

Fluid Resuscitation in Septic Shock Patients With BMI Elevation

NCT04759989

COMPLETED NA

Testing the Feasibility of a Simplified Workflow for Lung Cancer

NCT04844736

COMPLETED NA

Essential Oils Following IUD Insertion

NCT04927741

COMPLETED Phase 2

Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy

NCT04415944

← Previous Page 8 of 23 Next →

Phase Distribution

PhaseTrial count
Phase 1 96
Phase 2 143
Phase 3 31
Phase 4 80

What is open in the Wake Forest University Health Sciences pipeline

174 recruiting of 1,140 indexed (15% open); 724 completed (64%).

Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).

Top condition: Breast Cancer (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Wake Forest University Health Sciences: open-pipeline peers nationwide

Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 8%10%12%14%16%18%20% Total trials Recruiting share Wake Forest University Health SciencesUniversity of Alabama at BirminghamNYU Langone HealthUniversity of North Carolina, Chapel HillUniversity of FloridaBaylor UniversityCornell UniversityArrowhead Regional Medical CenterAurinia Pharmaceuticals
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,140 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Wake Forest University Health Sciences page

1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.

  • 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.